MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Cardiovascular
  • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • Whitepapers
  • DeviceTalks
You are here: Home / Regulatory/Compliance / Food & Drug Administration (FDA) / 510(k) / FDA clarifies refuse-to-accept policy for 510(k) applications

FDA clarifies refuse-to-accept policy for 510(k) applications

September 16, 2019 By Nancy Crotti Leave a Comment

FDA-logo-newThe FDA has updated its final guidance on its “refuse-to-accept” policy for 510(k) submissions.

The guidance includes detailed checklists for devices that applicants want to be considered for traditional, abbreviated or special 510(k) clearance. The agency said it will respond to applications within 15 calendar days from submission and will notify applicants if information is missing. When the applicant submits that information, the 15-day acceptance review cycle will begin again.

Applicants who deliberately omit information included in the checklist must give the agency a reason for why the question(s) do not apply to its device.

At any time during the 15-day period, the FDA may notify the applicant of its refusal to accept the application. Once it accepts an application, the FDA will begin its substantive review of the quality of the information provided.

The new final guidance is the latest in a series of documents on the agency’s refuse-to-accept policy. The first guidances, issued in 1993 and 1994 were not specific enough and caused FDA staff to invest “sigificant time in constructing extensive letters requesting all of the additional information needed to conduct a substantive review,” the agency said last week.

A third guidance, issued in 2012, clarified the content needed for traditional, abbreviated and special 510(k) submissions to allow the FDA to conduct a substantive review. The new guidance is intended to give FDA staff a clear, consistent approach for acceptance review for 510(k) applications and to outline the agency’s refuse-to-accept policy on 510(k)s. It will also help submitters prepare 510(k) notifications that are administratively complete for the FDA to conduct a substantive review, the agency said.

Filed Under: 510(k), Featured, Food & Drug Administration (FDA), News Well, Regulatory/Compliance Tagged With: FDA

In case you missed it

  • CryoLife wins CE Mark for E-nya thoracic stent graft
  • Edwards projects $5 billion in sales for 2020
  • SPR Therapeutics announces 1000th placement of nerve stimulation device
  • The best places to work for medtech sales reps
  • DePuy Synthes issues urgent field safety notice for USS II Polyaxial 3D heads
  • Haemonetics (HAE) launches SafeTrace Tx in North America
  • Vicarious Surgical wins FDA breakthrough designation for surgical robot
  • Natus Medical issues field safety notice for snap electrode leads
  • J&J’s Ethicon gets to substitute 20 new claims on surgical stapler patent
  • Minerva Surgical raises $10m
  • Leo Pharma, Portal Instruments partner to develop needle-free drug delivery device
  • Orthofix names new president of global spine business
  • J&J Vision launches Tecnis Toric II intraocular lens in U.S.
  • NOUS Imaging picks up $6.6m for brain-imaging software
  • MicroVention issues safety notice for Azur endovascular embolization products
  • New study touts positive long-term results for Boston Sci’s Watchman
  • 3M issues safety notice for Durapore Advanced surgical tape

RSS From Medical Design & Outsourcing

Leave a Reply Cancel reply

You must be logged in to post a comment.

Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Popular Posts

  • Report: SEC probes GE Healthcare, Philips, Siemens in Chinese bribery scheme
  • Edwards Lifesciences warns against below-market mini-tender offer Edwards Lifesciences
  • J&J’s Ethicon files ITC complaint against Intuitive Surgical Intuitive Surgical's EndoWrist instruments
  • Auris Health loses motion to move Intuitive Surgical patent suit from Del. to Cali. Johnson & Johnson's Auris, Intuitive Surgical
  • Enable Injections inks deal with Sanofi for drug delivery platform enfuse-enable-injections
Tweets by @MassDevice
MDO ad

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS